The renal effect of replacement fluids in controlled severe hemorrhagic shock: An experimental study

Ulusal Travma ve Acil Cerrahi Dergisi

Volumn 15, Issue 5, 2009, Pages 423-432

  Adanir, Tayfun ^a   Aksun, Murat ^a   Cirit, Mustafa ^a   Alkan Taşli, Funda ^b   Şahin, Osman ^a   Kestelli, Mert ^a   Aydin Kantaroǧlu, Tuba ^a   Köseoǧlu, Mehmet ^a   Şencan, Atilla ^a   Karahan, Nagihan ^a  

^a ATATURK TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b Izmir Training and Research Hospital ^*  (Turkey)

Author keywords

Hemorrhagic shock; Hydroxyethyl starch; Renal injury; Ringer's lactate

Indexed keywords

ALPHA 1 MICROGLOBULIN; CREATININE; CYSTATIN C; HETASTARCH; INTERLEUKIN 6; LACTATE DEHYDROGENASE; LACTIC ACID; N ACETYL BETA GLUCOSAMINIDASE; RINGER LACTATE SOLUTION; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DAMAGE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE SEVERITY; GLOMERULUS; HEMORRHAGIC SHOCK; HISTOPATHOLOGY; INFLAMMATION; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY TUBULE FUNCTION; KIDNEY TUBULE NECROSIS; LACTATE BLOOD LEVEL; LACTATE DEHYDROGENASE BLOOD LEVEL; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; RABBIT; RESUSCITATION; SUBSTITUTION THERAPY; UREA NITROGEN BLOOD LEVEL;

ANIMALS; BLOOD UREA NITROGEN; CREATININE; DISEASE MODELS, ANIMAL; FLUID THERAPY; HETASTARCH; ISOTONIC SOLUTIONS; KIDNEY; MALE; PLASMA SUBSTITUTES; PROTECTIVE AGENTS; RABBITS; RANDOM ALLOCATION; RESUSCITATION; SHOCK, HEMORRHAGIC;

EID: 69749089554     PISSN: 1306696X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. McCunn M, Dutton R. End-points of resuscitation how much is enough? Curr Opin Anaesthesiol 2000;13:147-153
2. Committee on Trauma. Advanced Trauma Life Support (ATLS) Course for Physicians instructor manual. Chicago: American College of Surgeons; 1997. p. 105-112
3. Ferreira EL, Terzi RG, Silva WA, de Moraes AC. Early colloid replacement therapy in a near-fatal model of hemorrhagic shock. Anesth Analg 2005;101:1785-1791
4. Boldt J. Hydroxyethylstarch as a risk factor for acute renal failure: is a change of clinical practice indicated? Drug Saf 2002;25:837-846
5. Moran M, Kapsner C. Acute renal failure associated with elevated plasma oncotic pressure. N Engl J Med 1987;317:150-153 (Pubitemid 17096463)
6. Legendre C, Thervet E, Page B, Percheron A, Noël LH, Kreis H. Hydroxyethylstarch and osmotic-nephrosis-like lesions in kidney transplantation. Lancet 1993;342:248-249 (Pubitemid 23214667)
7. Brunkhorst FM, Engel C, Bloos F, Meier-Hellmann A, Ragaller M, Weiler N, et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 2008;358:125-139
8. Godet G, Lehot JJ, Janvier G, Steib A, De Castro V, Coriat P. Safety of HES 130/0.4 (Voluven(R)) in patients with preoperative renal dysfunction undergoing abdominal aortic surgery: a prospective, randomized, controlled, parallel-group multicentre trial. Eur J Anaesthesiol 2008;25:986-994
9. Thiemermann C, Patel NS, Kvale EO, Cockerill GW, Brown PA, Stewart KN, et al. High density lipoprotein (HDL) reduces renal ischemia/reperfusion injury. J Am Soc Nephrol 2003;14:1833-1843.
10. Elmståhl B, Leander P, Grant D, Doughty RW, Chai CM, Björk J, et al. Histomorphological Changes after Renal X-Ray Arteriography Using Iodine and Gadolinium Contrast Media in an Ischemic Porcine Model. Acta Radiol 2007:1-11. (Pubitemid 350196147)
11. Cittanova ML, Leblanc I, Legendre C, Mouquet C, Riou B, Coriat P. Effect of hydroxyethylstarch in brain-dead kidney donors on renal function in kidney-transplant recipients. Lancet 1996;348(9042):1620-1622 (Pubitemid 27007061)
12. Cittanova ML, Mavré J, Riou B, Coriat P. Long-term follow-up of transplanted kidneys according to plasma volume expander of kidney donors. Intensive Care Med 2001;27:1830. (Pubitemid 33139849)
13. Schortgen F, Lacherade JC, Bruneel F, Cattaneo I, Hemery F, Lemaire F, et al. Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis: a multicentre randomised study. Lancet 2001;357:911-916 (Pubitemid 32247279)
14. Pinsky MR. Goals of resuscitation from circulatory shock. Contrib Nephrol 2004;144:94-104.
15. Davidson IJ. Renal impact of fluid management with colloids: a comparative review. Eur J Anaesthesiol 2006;23:721-738
16. Sakr Y, Payen D, Reinhart K, Sipmann FS, Zavala E, Bewley J, et al. Effects of hydroxyethyl starch administration on renal function in critically ill patients. Br J Anaesth 2007;98:216-224 (Pubitemid 47072001)
17. Winkelmayer WC, Glynn RJ, Levin R, Avorn J. Hydroxyethyl starch and change in renal function in patients undergoing coronary artery bypass graft surgery. Kidney Int 2003;64:1046-1049 (Pubitemid 37013841)
18. Boldt J, Brenner T, Lehmann A, Lang J, Kumle B, Werling C. Influence of two different volume replacement regimens on renal function in elderly patients undergoing cardiac surgery: comparison of a new starch preparation with gelatin. Intensive Care Med 2003;29:763-769 (Pubitemid 36609569)
19. Mahmood A, Gosling P, Vohra RK. Randomized clinical trial comparing the effects on renal function of hydroxyethyl starch or gelatine during aortic aneurysm surgery. Br J Surg 2007;94:427-433 (Pubitemid 46624720)
20. Jungheinrich C, Neff TA. Pharmacokinetics of hydroxyethyl starch. Clin Pharmacokinet 2005;44:681-699
21. Suttner S, Boldt J. Volume replacement with hydroxyethyl starch: is there an influence on kidney function? Anasthesiol Intensivmed Notfallmed Schmerzther 2004;39:71-77
22. Fenger-Eriksen C, Hartig Rasmussen C, Kappel Jensen T, Anker-Møller E, Heslop J, Frøkiaer J, et al. Renal effects of hypotensive anaesthesia in combination with acute normovolaemic haemodilution with hydroxyethyl starch 130/0.4 or isotonic saline. Acta Anaesthesiol Scand 2005;49:969-974 (Pubitemid 41076340)
23. Boldt J, Brosch C, Ducke M, Papsdorf M, Lehmann A. Influence of volume therapy with a modern hydroxyethylstarch preparation on kidney function in cardiac surgery patients with compromised renal function: a comparison with human albumin. Crit Care Med 2007;35:2740-2746 (Pubitemid 350175770)
24. Wiesen P, Canivet JL, Ledoux D, Roediger L, Damas P. Effect of hydroxyethylstarch on renal function in cardiac surgery: a large scale retrospective study. Acta Anaesthesiol Belg 2005;56:257-263 (Pubitemid 41474726)
25. Boldt J, Brosch Ch, Röhm K, Papsdorf M, Mengistu A. Comparison of the effects of gelatin and a modern hydroxyethyl starch solution on renal function and inflammatory response in elderly cardiac surgery patients. Br J Anaesth 2008;100:457-464 (Pubitemid 351773609)
26. Gaudio KM, Ardito TA, Reilly HF, Kashgarian M, Siegel NJ. Accelerated cellular recovery after an ischemic renal injury. Am J Pathol 1983;112:338-346
27. Page MK, Bükki J, Luppa P, Neumeier D. Clinical value of cystatin C determination. Clin Chim Acta 2000;297:67-72.
28. Dharnidharka VR, Kwon C, Stevens G. Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis. Am J Kidney Dis 2002;40:221-226 (Pubitemid 34827638)
29. Gormley SM, McBride WT, Armstrong MA, McClean E, MacGowan SW, Campalani G, et al. Plasma and urinary cytokine homeostasis and renal function during cardiac surgery without cardiopulmonary bypass. Cytokine 2002;17:61-65 (Pubitemid 34925857)
30. Sear JW. Kidney dysfunction in the postoperative period. Br J Anaesth 2005;95:20-32.
31. Krausz MM. Initial resuscitation of hemorrhagic shock. World J Emerg Surg 2006;1:14.
32. Watters JM, Tieu BH, Todd SR, Jackson T, Muller PJ, Malinoski D, et al. Fluid resuscitation increases inflammatory gene transcription after traumatic injury. J Trauma 2006;61:300-308 (Pubitemid 44265806)
33. Nascimento P Jr, de Paiva Filho O, de Carvalho LR, Braz JR. Early hemodynamic and renal effects of hemorrhagic shock resuscitation with lactated Ringer's solution, hydroxyethyl starch, and hypertonic saline with or without 6% dextran-70. J Surg Res 2006;136:98-105. (Pubitemid 44634549)
34. Boldt J, Priebe HJ. Intravascular volume replacement therapy with synthetic colloids: is there an influence on renal function? Anesth Analg 2003;96:376-382
35. Jungheinrich C, Scharpf R, Wargenau M, Bepperling F, Baron JF. The pharmacokinetics and tolerability of an intravenous infusion of the new hydroxyethyl starch 130/0.4 (6%, 500 mL) in mild-to-severe renal impairment. Anesth Analg 2002;95:544-551 (Pubitemid 35006837)
36. Cheung AT, To PL, Chan DM, Ramanujam S, Barbosa MA, Chen PC, et al. Comparison of treatment modalities for hemorrhagic shock. Artif Cells Blood Substit Immobil Biotechnol 2007;35:173-190 (Pubitemid 46514897)
37. Ferreira EL, Terzi RG, Silva WA, de Moraes AC. Early colloid replacement therapy in a near-fatal model of hemorrhagic shock. Anesth Analg 2005;101:1785-1791